About this trial
The study objective of this project is to examine the mechanisms of the venous distension reflex (VDR) in humans. We hypothesize that COX blockade with ketorolac tromethamine, an intravenous NSAID, will attenuate the muscle sympathetic nerve activity (MSNA) response to limb venous distension. To gain further insight into whether the COX byproducts directly stimulate chemically-sensitive afferents, or enable venodilation and indirectly evoke afferent stimulation, we will measure vein size using 3T MRI during venous distention with and without ketorolac infusions.
Eligibility criteria
Qualifiers
Are capable of giving informed consent
Are any race or ethnicity
Are fluent in written and spoken English
Have a satisfactory history and physical exam to meet inclusion/
Disqualifiers
Are free of acute or chronic medical conditions
Are 21 - 35 years of age (inclusive)
Weigh over 50 kg
Are less than 21 or over 35 years of age
Trial design
Treatments tested in this trial
- Wrist-to-elbow (W-E) occlusion
- ketorolac tromethamine
- saline control
Treatment groups
Sponsors and collaborators
Milton S. Hershey Medical Center
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator